Status: current, Defined. Date: 31-Oct 2022. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4753821000168115 | Pyridostigmine Bromide (Rising Pharmaceuticals) (pyridostigmine bromide 180 mg) modified release tablet, 30 tablets, bottle (containered trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4753831000168117 | Pyridostigmine Bromide (Rising Pharmaceuticals) 180 mg modified release tablet, 30, bottle | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Pyridostigmine Bromide (Rising Pharmaceuticals) 180 mg modified release tablet, 30, bottle | Is a | Pyridostigmine Bromide (Rising Pharmaceuticals) 180 mg modified release tablet, 30 | true | Inferred relationship | Some | ||
| Pyridostigmine Bromide (Rising Pharmaceuticals) 180 mg modified release tablet, 30, bottle | Is a | containered trade product pack | true | Inferred relationship | Some | ||
| Pyridostigmine Bromide (Rising Pharmaceuticals) 180 mg modified release tablet, 30, bottle | has container type | bottle | true | Inferred relationship | Some | ||
| Pyridostigmine Bromide (Rising Pharmaceuticals) 180 mg modified release tablet, 30, bottle | has TP | Pyridostigmine Bromide (Rising Pharmaceuticals) | true | Inferred relationship | Some | ||
| Pyridostigmine Bromide (Rising Pharmaceuticals) 180 mg modified release tablet, 30, bottle | has TPUU | Pyridostigmine Bromide (Rising Pharmaceuticals) 180 mg modified release tablet | true | Inferred relationship | Some | 920935399 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Containered trade product pack reference set
FHIR